Dr. Goldschmidt - ASH 2008 - Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma
Hartmut Goldschmidt, MD Universitätsklinikum Heidelberg und Nationales Centrum für Tumorerkrankungen Heidelberg, Germany Member, IMF Board of Scientific Advisors
12.28.08
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.